Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication.
about
Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral TherapyMutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment ResponsesEthanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals.Novel cell culture-adapted genotype 2a hepatitis C virus infectious cloneThe Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients.Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment Response.HCV genetic variability: from quasispecies evolution to genotype classification.Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture.Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment.Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis.Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients.Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection.Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma.In-Vitro Transcription analysis of NS5A from HCV-3a circulating in Pakistani patients with chronic hepatitis C and their differential response to antiviral therapy.
P2860
Q27486013-A8E012A5-4544-45EC-9DE8-624D20AB02EEQ27486410-A07E3978-F303-4061-8F6D-DC8001D0B504Q34075689-8CA40972-7106-41D4-9B57-45477D1E3B4BQ36276664-FE9F6FC7-B93B-414E-99FF-BC0982DA0814Q37006233-EE0C81A4-D73A-46A3-B22B-F60D659E0DF9Q37401160-62A63A08-DB05-4074-93F1-B512CFA9F101Q37425275-A6A7FBD4-4BA4-4E96-97FE-D21E37DD39A1Q38106964-80CECC8A-2E06-4B5D-A528-3D4768F207A3Q38121422-8900D5F1-A010-419E-BCE6-8E1B0C42E9ACQ39208854-FCA80796-741D-44C9-BFD5-001C94C1AC80Q42199023-C0C9B392-6BFB-404C-901E-5CA4B3A7037EQ42281044-B4DDB6AF-4226-43AB-91BD-800DE7FEE7BFQ42694877-EA753545-A534-4F06-B6DF-BBE140945576Q42980276-573D9DFE-FA9B-4A6F-8357-A6B023D84835Q43048165-005D4B9C-4DCB-459F-A21C-6842BDD86566Q47123261-DDDAC51B-9480-4833-9C09-426419EF4360
P2860
Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Site-specific mutation of the ...... hepatitis C virus replication.
@en
type
label
Site-specific mutation of the ...... hepatitis C virus replication.
@en
prefLabel
Site-specific mutation of the ...... hepatitis C virus replication.
@en
P2093
P2860
P1476
Site-specific mutation of the ...... hepatitis C virus replication.
@en
P2093
Kakinuma S
Kanazawa N
Kurosaki M
Nakagawa M
P2860
P304
P356
10.1111/J.1365-2893.2006.00739.X
P577
2006-09-01T00:00:00Z